Deal to lower drug costs for Americans and shield the drugmaker from import tariffs was the culmination of efforts stretching back to Novemb...

The US president told reporters he didn't think the deal would have been possible without his 100-percent tariff threat.

By WILL WEISSERT, Associated PressWASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce i...

The British government should not get complacent about AstraZeneca's U.S. listing, as it paves the way for a full one in New York.

Drugs giant AstraZeneca has revealed plans to overhaul its US listing, but stressed it will keep its headquarters in the UK and remain on th...

AstraZeneca has asked the Supreme Court to hear its case challenging the Medicare Drug Price Negotiation Program created through the Inflati...

The investment had been set to create 1,000 jobs

It comes after the pharmaceutical firm abandoned plans to invest £450 million in a vaccine plant in Merseyside earlier this year.

Stock market news and latest business and finance updates from Tuesday

The investment is expected to create tens of thousands of new, highly-skilled direct and indirect jobs across the country.

In today’s CEO Daily: Diane Brady talks to AstraZeneca CEO Pascal Soriot.The big story: Trump punishes the WSJ for its Epstein scoop....

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up...

Stock markets updates and business news from Friday

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca Plc’s chief ex...

Stock markets updates and business news from Wednesday